Financials data is unavailable for this security.
View more
Year on year Amgen Inc had little change in net income (from 6.55bn to 6.72bn) despite revenues that grew 7.09% from 26.32bn to 28.19bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 24.34% to 29.85%.
Gross margin | 63.30% |
---|---|
Net profit margin | 10.12% |
Operating margin | 20.81% |
Return on assets | 3.46% |
---|---|
Return on equity | 49.27% |
Return on investment | 4.39% |
More ▼
Cash flow in USDView more
In 2023, Amgen Inc increased its cash reserves by 43.45%, or 3.32bn. Cash Flow from Financing totalled 21.05bn or 74.66% of revenues. In addition the company generated 8.47bn in cash from operations while cash used for investing totalled 26.20bn.
Cash flow per share | 15.24 |
---|---|
Price/Cash flow per share | 21.80 |
Book value per share | 11.03 |
---|---|
Tangible book value per share | -79.79 |
More ▼
Balance sheet in USDView more
Current ratio | 1.26 |
---|---|
Quick ratio | 0.8928 |
Total debt/total equity | 10.57 |
---|---|
Total debt/total capital | 0.9136 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 2.85% |
---|---|
Div growth rate (5 year) | 10.04% |
Payout ratio (TTM) | 189.23% |
EPS growth(5 years) | -0.2187 |
---|---|
EPS (TTM) vs TTM 1 year ago | -60.84 |
More ▼